Table 2: Crude and adjusted cox-proportional hazard regression for predictors of death of the cohort at JUSH, February 10 to March 10, 2015.

Variables CHR [95%CI] p-value AHR [95%CI] p-value
Sex
  Male
 Female
1
5.6 [0.71,43.5]
0.10
1
6.14[0.78,48.34]
0.084
Age
 <25
 26-45
 >45
2.4[0.69,8.65]
1
2.3[0.27,18.6]
0.167
0.455
BMI
  <18.5
 >18.5
3.4[1.05,11.25]
1
0.042
2.21[1.93, 11.97]
1
0.049
Educational level
 Illiterate
 Primary
 Post-primary
1.35[0.23,8.08]
1
1.73[0.43,6.93]
0.75
0.44
Residence
  Urban
 Rural
1
1.66[0.49,5.69]
0.42
Religion
  Orthodox
 Muslims
 Others
1
0.66[0.17,2.55]
0.35[0.04,2.87]
0.55
0.33
Occupation
  Employed
 unemployed
 Housewife
1
0.87[0.25,3.09]
0.39[0.05,3.21]
0.83
0.38
Marital status
  Married
 Single
 Widowed
 Divorced
1
1.98[0.48,8.27]
0.56[0.07, 4.79]
2.89[0.56, 14.92]
0.35
0.60
0.204
Alcohol
  No
 Yes
1
1.18[0.31,4.46]
0.803
Baseline CD4+ count 0.89[0.981,0.998] 0.017 0.82[0.809,0.998] 0.019
WHO staging
  I
 II
 III
 IV
1
1.79[0.35,9.2]
0.74[0.10,5.2]
2.43[0.34,17.23]
0.488
0.76
0.375
TB (treatment)
  No
 Yes
1.49[0.19,11.67]
1
0.702
Regimen
  TDF group
 AZT group
0.83 [0.25,2.71]
1
0.753
0.67[0.2,2.24]
1
0.52
Prophylaxis
 CPT + INH
 CPT
 Neither		 1
1.27[0.26,6.11]
2.5[0.35,17.77]
1
0.75
0.359

BMI-body mass-index, AHR-adjusted hazard ratio, CHR-cumulative hazard ratio, INH-isoniazid, TB-tuberculosis, TDF-Tenofovir, AZT- Zidovudine, CPT-Cotrimoxazole prevent therapy